Sign in to view content

Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID

Rishi P. Singh, MD

Video
Published 2019

Rishi P. Singh, MD

Diabetic Retinopathy Part I Symposium

Related

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA
Nathan C. Steinle, MD
Annual Meeting Talks
2020
Potential Safety Concerns of Bevacizumab for Retinopathy of Prematurity
Robert L. Avery, MD
Annual Meeting Talks
2016

Category: Diabetic Retinopathy

See more